India added 19,079 coronavirus infections in the past 24 hours, placing its overall number at 1.03 crore cases, the Health Ministry's data showed. The number of fresh infections is 5 per cent lower than on Friday. In this period, India reported 224 deaths linked to the virus, taking the total number of fatalities to 1,49,218.
Meanwhile, a dry run to check the best way to vaccinate people against COVID-19 and plug loopholes in logistics and training will be held in all the states today. This drive will also test the operational feasibility in the use of CoWIN application in a field environment. Short for Covid Vaccine Intelligence Network, CoWIN is a digital platform to roll out and scale up the vaccination drive.
The massive exercise comes a day after a panel of government-appointed experts recommended approval for the Oxford COVID-19 vaccine, manufactured by Serum Institute of India, to the regulator Drugs Control Authority of India.
Here are the Highlights on Coronavirus Cases:
Jharkhand: Dry run for the administration of COVID19 vaccination was conducted at Sadar Hospital in Ranchi
- ANI (@ANI) January 2, 2021
Visuals from earlier in the day pic.twitter.com/fUQfL7bO16
Lucknow District Magistrate inspected dry run preparations for administering #COVID19 vaccine at the Lucknow Medical College
- ANI UP (@ANINewsUP) January 2, 2021
"Dry runs are being done at 6 locations in Lucknow district. The entire procedure of inoculation takes place in 5 stages," he says pic.twitter.com/amwLjuLc2T
"An emergency use certificate does need to factor in that there are certain unknowns about the vaccine and ensure there is a communication drive simultaneously": Anant Bhan, Reseacher pic.twitter.com/ocMVzbR4Of
- NDTV (@ndtv) January 2, 2021
A system to differentiate people with comorbidities is in the works to ensure those who are at a higher risk get vaccinated for COVID-19 first, the All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria told NDTV Friday. Read more
About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the United Kingdom, The Times reported.
AstraZeneca expects to supply two million doses of the vaccine in total by next week, the newspaper reported, citing an unnamed member of the Oxford-AstraZeneca team. "The plan is then to build it up fairly rapidly - by the third week of January we should get to two million a week," the report added.
The company was not immediately available to respond to a Reuters request for comment.
The report comes after Britain on Wednesday approved the Oxford-AstraZeneca COVID-19 vaccine, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.